clinical trial · NCT05864365
A Biomarker Study of ATH434 in Participants With MSA
Multiple System AtrophyATH434
brief summary
This study will assess the safety and efficacy of ATH434 in participants with a clinical diagnosis of Multiple System Atrophy
started
May 23, 2023
primary completion
Feb 26, 2025
completion
Feb 26, 2025
last updated
Apr 1, 2025
official title
An Open-Label Biomarker Study of ATH434 in Multiple System Atrophy
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol